Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 7 Thyroid Nodule 1 Pancreatic Cystic Neoplasm 1 Malignant Non-small Cell Neoplasm of Lung Stage Ia 1 Malignant Liver Neoplasm 1 Liver Neoplasms 1 Liver Diseases 1 Kidney Neoplasms 1 Colorectal Neoplasms 1 Cholangiocarcinoma 1 Bone Cancer Metastatic 1 Biliary Tract Neoplasms 1

Interventions

Sorafenib 5 Blood Specimen Collection 4 lenvatinib 3 sintilimab 2 pembrolizumab 2 ledipasvir, sofosbuvir drug combination 2 halofantrine 2 camrelizumab 2 atezolizumab 2 Liver Transplantation 2 Immunotherapy 2 Control Groups 2 Bevacizumab 2 Antibodies 2 veliparib 1 trifluridine tipiracil drug combination 1 trametinib 1 toripalimab 1 titanium silicide 1 tislelizumab 1 rubitecan 1 repotrectinib 1 pevonedistat 1 ozanimod 1 linifanib 1 genexol-PM 1 gadolinium ethoxybenzyl DTPA 1 fluorocholine 1 fisogatinib 1 ficlatuzumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Liver Diseases × Catheter Ablation × Clear all

NCT04727307 2025-09-30

AB-LATE02

University Hospital, Montpellier

Phase 2 Recruiting

Gastrointestinal

Carcinoma, Hepatocellular, Liver Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡